Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with <i>BRCA</i> mutation and/or maintenance therapy.

J Gynecol Oncol · 2024 · PMC11543250 · PMID 38551024

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

There was no statistically significant improvement in OS, but patients with CRS3 showed a trend toward better survival outcomes.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with &lt;i&gt;BRCA&lt;/i&gt; mutation and/or maintenance therapy.

The sentences

Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with <i>BRCA</i> mutation and/or maintenance therapy.